The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation

被引:9
作者
Boehm, Michael [1 ]
Herzog, Rebecca [1 ,2 ]
Klinglmueller, Florian [3 ]
Lichtenauer, Anton M. [1 ]
Wagner, Anja [1 ,2 ]
Unterwurzacher, Markus [1 ,2 ]
Beelen, Robert H. J. [4 ]
Alper, Seth L. [5 ,6 ]
Aufricht, Christoph [1 ]
Kratochwill, Klaus [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Pediat Nephrol & Gastroenterol, Vienna, Austria
[2] Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria
[3] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst CeMSIIS, Vienna, Austria
[4] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[5] Beth Israel Deaconess Med Ctr, Div Nephro, Boston, MA 02215 USA
[6] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
关键词
N(2)-alanyl-L-glutamine; cytoprotective additive; in vivo proteomics; mesothelial cells; peritoneal immune response; PD rat model; animal model; MESOTHELIAL CELLS; NLRP3; INFLAMMASOME; STRESS RESPONSES; FLUIDS; BICARBONATE;
D O I
10.3389/fphys.2019.00472
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Peritoneal dialysis (PD) fluids are cytotoxic to the peritoneum. Recent studies have shown that alanyl-glutamine (AlaGln) modulates the cellular stress response, improves mesothelial cell survival, reduces submesothelial thickening in experimental models of PD, and in clinical studies improves PD effluent cell stress and immune responses. However, the mechanisms of AlaGln-mediated membrane protection are not yet fully understood. Here, we explore those mechanisms through application of a novel proteomics approach in a clinically relevant in vivo model in rats. Experimental PD was performed for 5 weeks using conventional single-chamber bag (SCB) or neutral dual-chamber bag (DCB), PD fluid (PDF), with or without AlaGln supplementation, via a surgically implanted catheter. Rats subjected to a single dwell without catheter implantation served as controls. The peritoneal surface proteome was directly harvested by detergent extraction and subjected to proteomic analysis by two-dimensional difference gel electrophoresis (2D-DiGE) with protein identification by mass spectrometry. An integrated bioinformatic approach was applied to identify proteins significantly affected by the treatments despite biological variation and interfering high abundance proteins. From 505 of 744 common spots on 59 gels, 222 unique proteins were identified. Using UniProt database information, proteins were assigned either as high abundance plasma proteins, or as cellular proteins. Statistical analysis employed an adapted workflow from RNA-sequencing, the trimmed mean of M-values (TMM) for normalization, and a mixed model for computational identification of significantly differentially abundant proteins. The most prominently enriched pathways after 5 weeks chronic treatment with SCB or DCB, PDFs belonged to clusters reflecting tissue damage and cell differentiation by cytoskeletal reorganization, immune responses, altered metabolism, and oxidative stress and redox homeostasis. Although the AlaGln effect was not as prominent, associated enriched pathways showed mostly regression to control or patterns opposite that of the PDF effect. Our study describes the novel peritoneal surface proteome through combined proteomic and bioinformatic analyses, and assesses changes elicited by chronic experimental PD. The biological processes so identified promise to link molecular mechanisms of membrane damage and protection in the in vivo rat model to pathomechanisms and cytoprotective effects observed in vitro and in clinical PD.
引用
收藏
页数:17
相关论文
共 31 条
[1]   Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing [J].
Abbas-Aghababazadeh, Farnoosh ;
Li, Qian ;
Fridley, Brooke L. .
PLOS ONE, 2018, 13 (10)
[2]   Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network [J].
Aufricht, Christoph ;
Beelen, Robert ;
Eberl, Matthias ;
Fischbach, Michel ;
Fraser, Donald ;
Joerres, Achim ;
Kratochwill, Klaus ;
LopezCabrera, Manuel ;
Rutherford, Peter ;
Schmitt, Claus-Peter ;
Topley, Nicholas ;
Witowski, Janusz .
KIDNEY INTERNATIONAL, 2017, 92 (04) :824-835
[3]   Peritoneal Albumin and Protein Losses Do Not Predict Outcome in Peritoneal Dialysis Patients [J].
Balafa, Olga ;
Halbesma, Nynke ;
Struijk, Dirk G. ;
Dekker, Friedo W. ;
Krediet, Raymond T. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (03) :561-566
[4]   Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy [J].
Bartosova, Maria ;
Schaefer, Betti ;
Bermejo, Justo Lorenzo ;
Tarantino, Silvia ;
Lasitschka, Felix ;
Macher-Goeppinger, Stephan ;
Sinn, Peter ;
Warady, Bradley A. ;
Zaloszyc, Ariane ;
Parapatics, Katja ;
Majek, Peter ;
Bennett, Keiryn L. ;
Oh, Jun ;
Aufricht, Christoph ;
Schaefer, Franz ;
Kratochwill, Klaus ;
Schmitt, Claus Peter .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (01) :268-282
[5]   Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells [J].
Bender, Thorsten O. ;
Boehm, Michael ;
Kratochwill, Klaus ;
Vargha, Regina ;
Riesenhuber, Andrea ;
Witowski, Janusz ;
Joerres, Achim ;
Wieslander, Anders ;
Aufricht, Christoph .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) :1046-1052
[6]   HSP-MEDIATED CYTOPROTECTION OF MESOTHELIAL CELLS IN EXPERIMENTAL ACUTE PERITONEAL DIALYSIS [J].
Bender, Thorsten O. ;
Boehm, Michael ;
Kratochwill, Klaus ;
Lederhuber, Hans ;
Endemann, Michaela ;
Bidmon, Bettina ;
Aufricht, Christoph .
PERITONEAL DIALYSIS INTERNATIONAL, 2010, 30 (03) :294-299
[7]   Normalyzer: A Tool for Rapid Evaluation of Normalization Methods for Omics Data Sets [J].
Chawade, Aakash ;
Alexandersson, Erik ;
Levander, Fredrik .
JOURNAL OF PROTEOME RESEARCH, 2014, 13 (06) :3114-3120
[8]   Peritoneal dialysis-current status and future challenges [J].
Davies, Simon J. .
NATURE REVIEWS NEPHROLOGY, 2013, 9 (07) :399-408
[9]   BIOCOMPATIBLE DIALYSIS SOLUTIONS PRESERVE PERITONEAL MESOTHELIAL CELL AND VESSEL WALL INTEGRITY. A CASE-CONTROL STUDY ON HUMAN BIOPSIES [J].
del Peso, Gloria ;
Antonio Jimenez-Heffernan, Jose ;
Selgas, Rafael ;
Remon, Cesar ;
Ossorio, Marta ;
Fernandez-Perpen, Antonio ;
Antonio Sanchez-Tomero, Jose ;
Cirugeda, Antonio ;
de Sousa, Erika ;
Sandoval, Pilar ;
Diaz, Raquel ;
Lopez-Cabrera, Manuel ;
Auxiliadora Bajo, Maria .
PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (02) :129-134
[10]   Normal and Pathologic Concentrations of Uremic Toxins [J].
Duranton, Flore ;
Cohen, Gerald ;
De Smet, Rita ;
Rodriguez, Mariano ;
Jankowski, Joachim ;
Vanholder, Raymond ;
Argiles, Angel .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07) :1258-1270